Phosphate binder use, by DOPPS country and cross-section

  N Ptnts Total N Wgtd %
DOPPS Country DOPPS Cross-section 465 512 91.3%
AusNZ D2(2002)
D3(2006) 469 508 91.7%
D3(2007) 442 474 93.0%
D4(2010) 267 306 86.4%
Belgium D2(2002) 481 536 89.5%
D3(2006) 428 495 85.5%
D3(2007) 345 410 82.5%
D4(2010) 334 433 77.4%
Canada D2(2002) 556 587 95.1%
D3(2006) 503 540 92.5%
D3(2007) 410 443 90.7%
D4(2010) 271 305 88.0%
France D2(2002) 408 506 82.8%
D3(2006) 438 545 81.0%
D3(2007) 447 540 84.1%
D4(2010) 252 309 81.2%
Germany D2(2002) 454 559 81.6%
D3(2006) 480 570 85.4%
D3(2007) 522 619 85.5%
D4(2010) 431 542 79.4%
Italy D2(2002) 444 564 76.7%
D3(2006) 408 506 78.5%
D3(2007) 438 540 77.4%
D4(2010) 369 430 86.5%
Japan D2(2002) 1,408 1,763 80.9%
D3(2006) 1,550 1,820 85.3%
D3(2007) 1,511 1,839 82.0%
D4(2010) 1,409 1,691 83.3%
Spain D2(2002) 556 609 91.3%
D3(2006) 571 659 85.8%
D3(2007) 456 550 82.7%
D4(2010) 443 549 81.1%
Sweden D2(2002) 492 534 91.6%
D3(2006) 465 530 86.5%
D3(2007) 449 504 88.9%
D4(2010) 375 435 86.2%
UK D2(2002) 438 552 77.7%
D3(2006) 340 432 79.6%
D3(2007) 271 337 83.1%
D4(2010) 279 370 76.5%
US D2(2002) 1,919 2,230 86.1%
D3(2006) 1,555 1,791 88.2%
D3(2007) 1,141 1,308 87.0%
D4(2010) 2,691 3,112 85.0%

Percent of patients prescribed any phosphate binder in previous week, among all patients

Please see additional methodological information in the Data Sources and Methods section.